EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2025-03-27
Management highlights
• Maintained pricing discipline despite weak market conditions and drove market share gains. • Focused on managing cost structure and optimizing portfolio mix to reach >20% EBITDA margin target. • Utilized global sourcing infrastructure where 97% of products sold in a region are produced there, acting as a hedge against currency and tariffs. • Streamlining cost structure, improving operational efficiency, and looking forward to updates at Investor Day in October.
Segment performance
In HHC, organic revenue was up 4% year on year with solid volume growth and positive pricing, but EBITDA margin was 12.7% (down). Engineering adhesives had organic revenue decline 2% in Q1, but EBITDA increased 16% with margin at 18.7%. Building Adhesive Solutions (BAS) had organic sales up 2% y/y, EBITDA up 2%. America's organic revenue was down 1% y/y, but BAS achieved over 8% organic growth. EIMIA had organic revenue up 4% y/y, and Asia Pacific organic revenue up 7% y/y.
Guidance
• Reiterated 2025 guidance: net revenue down 2%-4%, organic revenue flat to up 2% y/y. • Adjusted EBITDA expected in range of $600M-$625M (1%-5% y/y growth). • Full-year adjusted EPS range $3.90-$4.20 (2%-9% y/y growth). • Operating cash flow expected $300M-$325M, weighted to second half. • Q2 EBITDA expected $150M-$160M.
Risks
• Weak overall market demand and unpredictable geopolitical conditions. • Impact of raw material costs on margins. • Currency fluctuations affecting financial performance.
Q&A highlights
Q: Can you give a sense of customers' thinking through volatility and prebuying in front of tariffs?
A: No significant prebuying seen, customers cautious but focused on innovation. In HHC, repositioning in hygiene and winning with innovation. Solar business margins improving as moving to higher-end panels.
Q: Outlook for HHC margin restoration?
A: Expect improving margins in HHC, aiming for 16%-17% EBITDA margin range, with pricing increases realized and raw material impact subsiding.
Q: Thoughts on working capital and cash flow?
A: Working capital increase due to volume/pricing growth, but normalized trends and self-help actions expected to improve working capital as percentage throughout year.
Q: March demand and seasonal uptick?
A: Saw strong phase three in Q1, continuing progression, no push out/movement of volumes, volume growth expected flat rest of year.
Q: China market trends?
A: Mid to high single-digit growth in China, HHC and EA businesses performing well, repositioning EA away from solar into other applications.
Q: Tesla Cybertruck recall and Fuller adhesive?
A: Not Fuller product, but opportunity in automotive exterior trim with structural adhesives.
Q: Raw materials and HHC impact?
A: Raw materials inflation affecting HHC, but flat sequentially from Q4 to Q1, expecting favorable comparisons as annualizing against last year's increases.
Q: Nonrecurring charges?
A: Estimated nonrecurring charges around $40-50M pre-tax for remainder of year, with acquisition costs decreasing.
Q: Europe and US economy trends?
A: Half of 30 market segments accelerating, US consumer weak, Europe construction market not good but HHC in Europe had share wins.
Q: Tariffs impact on customers?
A: Hard to quantify indirect impact, but H.B. Fuller positioned well in recession with ability to drive down raw material costs.
Q: PFAS replacement products?
A: Working on PFAS-free alternatives, leading in market with innovation, particularly in electronics.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | — | — | — | — |
| Revenue | — | — | — | — |
Transcript
March 27, 2025Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.